Liraglutide

July 20, 2023

Liraglutide is a GLP-1 analog and a medication used to treat diabetes mellitus type 2 and obesity. in which lysine at position 34 has been replaced with arginine, and palmitic acid has been attached via glutamoyl spacer to lysine at position 26. No animal-derived raw materials or excipients are used in the production of liraglutide. The drug product is a solution for subcutaneous injection containing 6.0 mg/ml of the drug substance presented in a pre-filled, multi-dose pen-injector. Unlike GLP-1, liraglutide has a pharmacokinetic and pharmacodynamic profile in human suitable for once daily administration.
Liraglutide is also a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as incretin mimetics. It works by increasing insulin release from the pancreas and decreases excessive glucagon release.


Status:In Mass Production
Unit:5mg,10mg,1g/customized
Capacity: 1kg/month

Request a Quick Quote

Raw Liraglutide powder (204656-20-2) video

Liraglutide Description

Liraglutide is a GLP-1 analog and a medication used to treat diabetes mellitus type 2 and obesity. in which lysine at position 34 has been replaced with arginine, and palmitic acid has been attached via glutamoyl spacer to lysine at position 26. No animal-derived raw materials or excipients are used in the production of liraglutide. The drug product is a solution for subcutaneous injection containing 6.0 mg/ml of the drug substance presented in a pre-filled, multi-dose pen-injector. Unlike GLP-1, liraglutide has a pharmacokinetic and pharmacodynamic profile in human suitable for once daily administration.

Liraglutide is also a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) also known as incretin mimetics. It works by increasing insulin release from the pancreas and decreases excessive glucagon release.

Liraglutide Specifications

Product NameLiraglutide
Chemical NameGlycine,L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-;Liraglutida;Liraglutida [inn-spanish];Liraglutide [usan:inn];
Brand NameVictoza
Drug ClassPeptide
CAS Number204656-20-2
InChIKeyKAIWQAZASNVPLR-QCIJIYAXSA-N
Molecular FormulaC172H265N43O51
Molecular Weight3751.262 g/mol
Monoisotopic Mass3748.946 g/mol
Melting Point >182°C (dec.)
Biological Half-Lifeapproximately 13 hours.
ColorN/A
Solubility Soluble in DMSO
Storage Temperature Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Applicationused as a hypoglycemic agent and supplemental therapy in the treatment of Diabetes by patients who do not respond to Metformin, to treat diabetes mellitus type 2 and obesity.

Contact Us

Polypeptide Peptide dosage calculator